Skip to content
10-Q

Quarterly Report

KYMERA THERAPEUTICS, INC. KYMR

0001193125-25-263550

← back to feed
Filed
Nov 4, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 31, 2025 71.95M sh
Shares Diluted Q3 2025 · Sep 30, 2025 87.3M sh
Shares Diluted Q3 2025 · Sep 30, 2025 82.65M sh
Shares Diluted Q3 2025 · Sep 30, 2024 76.13M sh
Shares Diluted Q3 2025 · Sep 30, 2024 73.33M sh
Capex Q3 2025 · Sep 30, 2025 $1.34M
Capex Q3 2025 · Sep 30, 2024 $11.9M
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$166.14M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$132.72M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $112.95M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $120.26M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $110.72M
Stockholders Equity Q3 2025 · Sep 30, 2025 $946.26M
Stockholders Equity Q3 2025 · Jun 30, 2025 $971.48M
Stockholders Equity Q3 2025 · Dec 31, 2024 $835.62M
Stockholders Equity Q3 2025 · Sep 30, 2024 $892.93M
Stockholders Equity Q3 2025 · Jun 30, 2024 $684.92M
Stockholders Equity Q3 2025 · Dec 31, 2023 $394.97M
Current Liabilities Q3 2025 · Sep 30, 2025 $71.58M
Current Liabilities Q3 2025 · Dec 31, 2024 $67.77M
Total Liabilities Q3 2025 · Sep 30, 2025 $155.79M
Total Liabilities Q3 2025 · Dec 31, 2024 $142.42M
Current Assets Q3 2025 · Sep 30, 2025 $528.3M
Current Assets Q3 2025 · Dec 31, 2024 $510.27M
Total Assets Q3 2025 · Sep 30, 2025 $1.1B
Total Assets Q3 2025 · Dec 31, 2024 $978.04M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.94
Eps Diluted Q3 2025 · Sep 30, 2025 −$2.71
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.82
Eps Diluted Q3 2025 · Sep 30, 2024 −$2.09
Eps Basic Q3 2025 · Sep 30, 2025 −$0.94
Eps Basic Q3 2025 · Sep 30, 2025 −$2.71
Eps Basic Q3 2025 · Sep 30, 2024 −$0.82
Eps Basic Q3 2025 · Sep 30, 2024 −$2.09
Sga Expense Q3 2025 · Sep 30, 2025 $17.34M
Sga Expense Q3 2025 · Sep 30, 2025 $51.25M
Sga Expense Q3 2025 · Sep 30, 2024 $15.46M
Sga Expense Q3 2025 · Sep 30, 2024 $47.2M
Rd Expense Q3 2025 · Sep 30, 2025 $74.09M
Rd Expense Q3 2025 · Sep 30, 2025 $232.74M
Rd Expense Q3 2025 · Sep 30, 2024 $60.41M
Rd Expense Q3 2025 · Sep 30, 2024 $168.43M
Net Income Q3 2025 · Sep 30, 2025 −$82.18M
Net Income Q3 2025 · Sep 30, 2025 −$224.37M
Net Income Q3 2025 · Sep 30, 2024 −$62.49M
Net Income Q3 2025 · Sep 30, 2024 −$153.11M
Operating Income Q3 2025 · Sep 30, 2025 −$92.52M
Operating Income Q3 2025 · Sep 30, 2025 −$251.5M
Operating Income Q3 2025 · Sep 30, 2024 −$72.12M
Operating Income Q3 2025 · Sep 30, 2024 −$180.88M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $2.76M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $36.34M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $3.74M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $39.68M
Revenue Q3 2025 · Sep 30, 2025 $2.76M
Revenue Q3 2025 · Sep 30, 2025 $36.34M
Revenue Q3 2025 · Sep 30, 2024 $3.74M
Revenue Q3 2025 · Sep 30, 2024 $39.68M